GSK and Fleming Initiative scientists unite to target AMR with advanced AI
Imperial wins Outstanding Entrepreneurial University at THE Awards
Imperial celebrates impact of supporters who gave £77.5 million in 2024-25
Alaa Riezk interview with Technology Networks
Find out more
Identifing potential adulterants for further analysis using the facilities within the AMS.
Using Agilent’s automated liquid handling application to extract the most data points possible from d-ISF samples.
Oscar Ces interview with Technology Networks
Alaa Riezk Interview with Innovations Pharmaceutical Technology
Using analytical facilities of the AMS to quantify the dose of drugs delivered to the brain.
A new podcast series brought to you by Agilent Technologies in partnership with Imperial
Brad Hocking interview with The Medicine Maker